http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104774194-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-05 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-22 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C269-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
| filingDate | 2014-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104774194-B |
| titleOfInvention | Deuterated Hepatitis C Virus Inhibitors |
| abstract | The invention belongs to the field of medicinal chemistry, and in particular relates to a deuterated hepatitis C virus inhibitor, a preparation method thereof, a pharmaceutical composition containing the inhibitor, and the inhibitor and the pharmaceutical composition thereof are used in the preparation of medicines for treating hepatitis C virus infection use in . The compound of formula I of the present invention has excellent pharmacokinetic properties, so it is suitable as a compound for inhibiting hepatitis C virus protein NS5A, and further suitable for preparing a medicine for treating hepatitis C virus infection. |
| priorityDate | 2014-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.